Dr. Senderoff has over 30 years experience characterizing and developing drug products within the pharmaceutical and biopharmaceutical industries. Dr. Senderoff has extensive experience working on antibodies, antibody-related products, cytokines, pegylated cytokines, growth factors, blood coagulation factors, peptides, small molecules, and natural products.  These efforts involved leading and coordinating analytical and process/product development activities addressing liquid & lyophilized formulations, biologic-device combinations, alternative administration forms, unit process design, transfer, scale-up, toxicological/clinical manufacturing, characterization/validation, specification selection/justification, as well as drafting regulatory documents.  Rich has previously worked at Parke-Davis Pharmaceutical Research/Warner-Lambert Company (now Pfizer) and ZymoGenetics (now Bristol Myers Squibb).  He has been an independent consultant helping many companies since 2009.   Dr. Senderoff received his B.S. in Pharmacy from Philadelphia College of Pharmacy & Science (1985) and his Ph.D. in Pharmaceutics from Ohio State University (1990).